Iovance Biotherapeutics (IOVA) Property, Plant & Equipment (Net) Growth (3y) (2014 - 2026)
Powered by 
Analysis
Iovance Biotherapeutics (IOVA) Property, Plant & Equipment (Net) Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 14.05% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 11.65% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 411.50% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -3.34% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 16.78% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.66% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 19.96% |
| 10 | Iovance Biotherapeutics | 3.95 Bn | 3.66 Bn | 55.72 Mn | 5.31% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.31% |
| Mar 31, 2026 | 6.13% |
| Dec 31, 2025 | 7.60% |
| Sep 30, 2025 | 7.93% |
| Jun 30, 2025 | 6.58% |
| Mar 31, 2025 | 2.79% |
| Dec 31, 2024 | 2.62% |
| Mar 31, 2024 | 15.40% |
| Dec 31, 2023 | 24.45% |
| Sep 30, 2023 | 42.49% |
| Jun 30, 2023 | 81.82% |
| Mar 31, 2023 | 100.65% |
| Dec 31, 2022 | 131.01% |
| Sep 30, 2022 | 158.15% |
| Jun 30, 2022 | 182.81% |
| Mar 31, 2022 | 208.38% |
| Dec 31, 2021 | 235.08% |
| Sep 30, 2021 | 221.87% |
| Jun 30, 2021 | 209.36% |
| Mar 31, 2021 | 218.72% |